These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7534709)

  • 1. The dihydropyridine nitrendipine inhibits [3H]MK 801 binding to mouse brain sections.
    Filloux FM; Fitts RC; Skeen GA; White HS
    Eur J Pharmacol; 1994 Nov; 269(3):325-30. PubMed ID: 7534709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons.
    Skeen GA; Twyman RE; White HS
    Mol Pharmacol; 1993 Aug; 44(2):443-50. PubMed ID: 8394997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK; Bolger GT
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR; Donowitz M; Weiland GA; Sharp GW
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P
    J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropyridine binding sites regulate calcium influx through specific voltage-sensitive calcium channels in cerebellar granule cells.
    Carboni E; Wojcik WJ
    J Neurochem; 1988 Apr; 50(4):1279-86. PubMed ID: 2450173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
    O'Neill SK; Triggle CR; Bolger GT
    Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dihydropyridine nitrendipine reduces N-methyl-D-aspartate (NMDA)-evoked currents of rodent cortical neurons through a direct interaction with the NMDA receptor-associated ion channel.
    Skeen GA; White HS; Twyman RE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):30-8. PubMed ID: 7965728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel 'agonist' BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes.
    Greenberg DA; Cooper EC; Carpenter CL
    Brain Res; 1984 Jul; 305(2):365-8. PubMed ID: 6204725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant properties of calcium channel blockers in mice: N-methyl-D-,L-aspartate- and Bay K 8644-induced convulsions are potently blocked by the dihydropyridines.
    Palmer GC; Stagnitto ML; Ray RK; Knowles MA; Harvey R; Garske GE
    Epilepsia; 1993; 34(2):372-80. PubMed ID: 7681002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells.
    Albus U; Habermann E; Ferry DR; Glossmann H
    J Neurochem; 1984 Apr; 42(4):1186-9. PubMed ID: 6199462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium.
    Melena J; Osborne NN
    Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAY K 8644, a 1,4-dihydropyridine Ca2+ channel activator: dissociation of binding and functional effects in brain synaptosomes.
    Rampe D; Janis RA; Triggle DJ
    J Neurochem; 1984 Dec; 43(6):1688-92. PubMed ID: 6208338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of phenylalkylamine calcium channel blockers with the 1,4-dihydropyridine binding site.
    Zobrist RH; Giacomini KM; Nelson WL; Giacomini JC
    J Mol Cell Cardiol; 1986 Sep; 18(9):963-74. PubMed ID: 3783730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The behavioral effects of the calcium agonist Bay K 8644 in the mouse: antagonism by the calcium antagonist nifedipine.
    Bolger GT; Weissman BA; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):373-7. PubMed ID: 2581145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of dihydropyridine binding sites with calcium-dependent neurotransmitter release in synaptosomes.
    Massieu L; Tapia R
    J Neurochem; 1988 Oct; 51(4):1184-9. PubMed ID: 2458434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of L- and N-type Ca2+ channel antagonists on excitatory amino acid-evoked dopamine release.
    Chaudieu I; Alonso R; Mount H; Quirion R; Boksa P
    Eur J Pharmacol; 1992 Sep; 220(2-3):203-9. PubMed ID: 1385182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine.
    Dolin SJ; Hunter AB; Halsey MJ; Little HJ
    Eur J Pharmacol; 1988 Jul; 152(1-2):19-27. PubMed ID: 2463174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids.
    Hallaq H; Smith TW; Leaf A
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1760-4. PubMed ID: 1371883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.